FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

被引:1408
作者
Shimada, T
Hasegawa, H
Yamazaki, Y
Muto, T
Hino, R
Takeuchi, Y
Fujita, T
Nakahara, K
Fukumoto, S
Yamashita, T
机构
[1] Kirin Brewery Co Ltd, Pharmaceut Res Labs, Takasaki, Gumma 3701295, Japan
[2] Univ Tokyo, Sch Med, Dept Med, Bunkyo Ku, Tokyo, Japan
[3] Tokyo Univ Hosp, Dept Lab Med, Bunkyo Ku, Tokyo, Japan
关键词
FGF-23; phosphatonin; phosphate metabolism; vitamin D metabolism; type IIa sodium-phosphate cotransporter;
D O I
10.1359/JBMR.0301264
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed the effects of an FGF-23 injection in vivo. FGF-23 caused a reduction in serum 1,25-dihydroxyvitamin D by altering the expressions of key enzymes for the vitamin D metabolism followed by hypophosphatemia. This study indicates that FGF-23 is a potent regulator of the vitamin D and phosphate metabolism. Introduction: The pathophysiological contribution of FGF-23 in hypophosphatemic diseases was supported by animal studies in which the long-term administration of recombinant fibroblast growth factor-23 reproduced hypophosphatemic rickets with a low serum 1,25-dihydroxyvitamin D [1,25(OH)(2)D] level. However, there is no clear understanding of how FGF-23 causes these changes. Materials and Methods: To elucidate the molecular mechanisms of the FGF-23 function, we investigated the short-term effects of a single administration of recombinant FGF-23 in normal and parathyroidectmized animals. Results: An injection of recombinant FGF-23 caused a reduction in serum phosphate and 1,25(OH)(2)D levels. A decrease in serum phosphate was first observed 9 h after the injection and was accompanied with a reduction in renal mRNA and protein levels for the type IIa sodium-phosphate cotransporter (NaPi-2a). There was no increase in the parathyroid hormone (PTH) level throughout the experiment, and hypophosphatemia was reproduced by FGF-23 in parathyroidectomized rats. Before this hypophosphatemic effect, the serum 1,25(OH)(2)D level had already descended at 3 It and reached the nadir 9 h after the administration. FGF-23 reduced renal mRNA for 25-hydroxyvitamin D-la-hydroxylase and increased that for 25-hydroxyvitamin D-24-hydroxylase starting at 1 h. In addition, an injection of calcitriol into normal mice increased the serum FGF-23 level within 4 h. Conclusions: FGF-23 regulates NaPi-2a independently of PTH and the serum 1,25(OH)(2)D level by controlling renal expressions of key enzymes of the vitamin D metabolism. In conclusion, FGF-23 is a potent regulator of phosphate and vitamin D homeostasis.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 25 条
[1]   The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency [J].
Bai, XY ;
Miao, DS ;
Goltzman, D ;
Karaplis, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9843-9849
[2]   Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities [J].
Beck, L ;
Karaplis, AC ;
Amizuka, N ;
Hewson, AS ;
Ozawa, H ;
Tenenhouse, HS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5372-5377
[3]   FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate [J].
Bowe, AE ;
Finnegan, R ;
de Beur, SMJ ;
Cho, J ;
Levine, MA ;
Kumar, R ;
Schiavi, SC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (04) :977-981
[4]   Vitamin D [J].
Brown, AJ ;
Dusso, A ;
Slatopolsky, E .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (02) :F157-F175
[5]   TUMOR-INDUCED OSTEOMALACIA - UNVEILING A NEW HORMONE [J].
ECONS, MJ ;
DREZNER, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) :1679-1681
[6]   Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. [J].
Jonsson, KB ;
Zahradnik, R ;
Larsson, T ;
White, KE ;
Sugimoto, T ;
Imanishi, Y ;
Yamamoto, T ;
Hampson, G ;
Koshiyama, H ;
Ljunggren, Ö ;
Oba, K ;
Yang, IM ;
Miyauchi, A ;
Econs, MJ ;
Lavigne, J ;
Jüppner, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1656-1663
[7]   IDENTIFICATION OF A VITAMIN-D RECEPTOR HOMODIMER-TYPE RESPONSE ELEMENT IN THE RAT CALCITRIOL 24-HYDROXYLASE GENE PROMOTER [J].
KAHLEN, JP ;
CARLBERG, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (03) :1366-1372
[8]   PARATHYROID-HORMONE ACTION ON PHOSPHATE TRANSPORTER MESSENGER-RNA AND PROTEIN IN RAT RENAL PROXIMAL TUBULES [J].
KEMPSON, SA ;
LOTSCHER, M ;
KAISSLING, B ;
BIBER, J ;
MURER, H ;
LEVI, M .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 268 (04) :F784-F791
[9]   MODIFIED PROCEDURE FOR RAPID PREPARATION OF EFFICIENTLY TRANSPORTING VESICLES FROM SMALL INTESTINAL BRUSH-BORDER MEMBRANES - THEIR USE IN INVESTIGATING SOME PROPERTIES OF D-GLUCOSE AND CHOLINE TRANSPORT-SYSTEMS [J].
KESSLER, M ;
ACUTO, O ;
STORELLI, C ;
MURER, H ;
MULLER, M ;
SEMENZA, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 506 (01) :136-154
[10]   Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia [J].
Larsson, T ;
Zahradnik, R ;
Lavigne, J ;
Ljunggren, Ö ;
Jüppner, H ;
Jonsson, KB .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (02) :269-276